ECP 2022 Final Programme

Monday, 5 Sept One-Day MD Symposium 73 ECP 2022 Basel MD-03 1-Day MD Symposium 14:45–16:45 Boston From biological and clinical data interpretation to molecular tumour board decisions Chairs: Gerald Höfler, Austria Caterina Marchiò, Italy 001 14:45–15:05 Application of cancer genome sequencing in diagnostic pathology Reinhard Büttner, Germany 002 15:05–15:25 Bioinformatics – the basics Peggy Weist, Germany Lukas Heukamp, Germany 003 15:25–15:45 TMB and decision tools in the national Norwegian basket/umbrella trial IMPRESS Sigve Nakken, Norway 004 15:45–16:05 Crowd validation of a national broad custom DNA/RNA-capture panel for pan-cancer diagnostics in pathology Johan Botling, Sweden 005 16:05–16:25 MTB-based discussion of data from tissue and liquid biopsies; the ROME trial Andrea Botticelli, Italy 006 16:25–16:45 Artificial intelligence in cancer therapy: the oncologist’s perspective Christoph Benedikt Westphalen, Germany MD-04 1-Day MD Symposium 17:15–19:15 Boston Future developments Chairs: Johan Botling, Sweden Sabine Merkelbach-Bruse, Germany 001 17:15–17:35 Deep learning approaches in cancer pathology Jakob Kather, Germany 002 17:35–17:55 Ex vivo drug sensitivity and resistance testing for malignant melanoma Laura Kohtamäki, Finland 003 17:55–18:15 AI for patient stratification and treatment response predictive Nasir Rajpoot, United Kingdom 004 18:15–18:35 Implementing nationwide whole genome sequencing for all children with cancer in Sweden David Gisselsson, Sweden 005 18:35–18:55 Extensive spatial-characterisation of the tumour-microenvironment in a large clinical non-small cell lung cancer cohort and correlation with clinical and pathological parameters Sharon Ruane, Ireland 006 18:55–19:15 AIRMEC–an artificial intelligence model to predict the molecular endometrial cancer classification from H&E images Tjalling Bosse, The Netherlands